Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Safety of ruxolitinib therapy prior to allogeneic hematopoietic stem-cell transplantation for myeloproliferative neoplasms. Bone Marrow Transplant 2016 Apr;51(4):617-8

Date

01/05/2016

Pubmed ID

26726940

DOI

10.1038/bmt.2015.295

Scopus ID

2-s2.0-84953295752 (requires institutional sign-in at Scopus site)   17 Citations

Author List

Hanif A, Hari PN, Atallah E, Carlson KS, Pasquini MC, Michaelis LC

Authors

Ehab L. Atallah MD Professor in the Medicine department at Medical College of Wisconsin
Karen-Sue B. Carlson MD, PhD Associate Professor in the Medicine department at Medical College of Wisconsin
Parameswaran Hari MD Adjunct Professor in the Medicine department at Medical College of Wisconsin
Laura Michaelis MD Chief, Professor in the Medicine department at Medical College of Wisconsin
Marcelo C. Pasquini MD, MS Professor in the Medicine department at Medical College of Wisconsin




MESH terms used to index this publication - Major topics in bold

Allografts
Female
Hematologic Neoplasms
Hematopoietic Stem Cell Transplantation
Humans
Male
Middle Aged
Nitriles
Primary Myelofibrosis
Pyrazoles
Pyrimidines